Can-Fite BioPharma (CANF) 6-K Current report (foreign)

CAN-FITE BIOPHARMA LTD.
	9/30/2013
UnauditedPro Forma Interim Consolidated Balance Sheet	$1 = NIS 3.537

									Convenience translation
				Shares and					Into
				options issuance		Proforma data			U.S. dollars.
	September 30,					September 30,			September 30,
	2013					2013			2013
	Unaudited					Unaudited			Unaudited
	NIS in thousands			NIS in thousands		NIS in thousands			In thousands
ASSETS
CURRENT ASSETS:
Cash and cash equivalents		9,673			21,292		30,965			8,755
Accounts receivable		1,615					1,615			457
		11,288			21,292		32,580			9,211
NON-CURRENT ASSETS:
Property, plant and equipment, net		157					157			44
		11,445			21,292		32,737			9,256
LIABILITIES AND EQUITY
CURRENT LIABILITIES:
Trade payables		2,046			1,154		3,200			905
Other accounts payable		2,502					2,502			707
Options exercisable into shares (series 6)		149					149			42
Options exercisable into shares (series 7)		159					159			45
Options exercisable into shares (series 8)		308					308			87
		5,164			1,154		6,318			1,786
NON-CURRENT LIABILITIES:
Options exercisable into shares (series 7)		-					-
Employee benefit liabilities, net		67					67			19
		5,231			1,154		6,385			1,805
EQUITY (DEFICIENCY) ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY:
Share capital		3,568			459		4,027			1,139
Share premium		250,782			16,781		267,563			75,647
Capital reserve from share-based payment transactions		15,561			159		15,720			4,444
Options exercisable into shares (series 9)		669					669			189
Options exercisable into shares (series 10)		3,178					3,178			899
Options exercisable into shares (series 11)		3,066					3,066			867
Options exercisable into shares (series 12)					2,739		2,739			774
Treasury shares		(3,628	)				(3,628	)		(1,026	)
Adjustments arising from translating financial statements of foreign operations		(117	)				(117	)		(33	)
Accumulated deficit		(269,371	)				(269,371	)		(76,158	)
		3,708			20,138		23,846			6,742
Non-controlling interests		2,506					2,506			709
Total equity		6,214			20,138		26,352			7,450
		11,445			21,292		32,737			9,256